Protecting the Public - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Protecting the Public
Overt and covert packaging technologies evolve to authenticate drugs and fight counterfeits.


Pharmaceutical Technology
Volume 36, Issue 11

Taggants. Taggants are microscopic/nano materials or chemistries that are uniquely encoded and virtually impossible to duplicate—like a fingerprint. The invisible taggants work at a low loading ratio yet are identifiable in the field via a handheld tester. Taggants can be delivered in raw material, plastic masterbatch, security ink, or spray carrier. Some taggants make it possible to detect mix ratios and dilution as low as 10% (Molecular Taggants, Microtrace).

Some taggant technology can be paired with smartphone authentication, thus eliminating the need for proprietary readers and opening the door to consumer-level authentication (TagSure taggant technology, SmartSure phone app, InkSure Technologies).

Taggant-equipped labels and cartons can be printed with invisible ink and item-level codes for authentication (taggants and inks, Covectra, labels and cartons from MSO Group). Software makes the covert technology compatible with serialization and track-and-trace requirements (AuthentiTrack software, Covectra).

Ink-based approaches. A technology with some similarity to taggants adds a standard or custom DNA strand to a visible or invisible security ink applied by a continuous inkjet printer. To authenticate the product, a sample is extracted from the printed component, loaded into a PCR reaction plate, and analyzed to confirm the presence of the DNA (Security Fluids, Oncode, a division of Gem Gravure, with DNA strands from DNA Technologies, a division of Polestar).

Another covert solution prints an invisible pattern of seemingly random microdots along with other graphic elements. A standard office scanner captures the resulting image for storage on a secure server and future authentication via an iPhone app (Cryptoglyph covert printed patterns, Genuine or Fake iPhone app, AlpVision).

Visible color security inks for continuous inkjet printers can be matched to a brand’s logo or other graphic elements, so brand owners can add security features without noticeable changes to the package’s appearance. A clear version of the security ink is also available. Proprietary markers in the ink are only visible to a custom reader (Traceless System, Eastman Kodak).

Continuous inkjet printers also apply unique codes or other data with ultraviolet (UV) inks. The covert codes can support authentication and track-and-trace functions (Linx Clear UV-readable inks 1121 and Linx 4900 CIJ printer, Linx Printing Technologies).

Another UV-based solution applies UV-ink-printed roll-fed labels to syringe barrels during the molding process. Labels are placed within +/- 0.010 in. to ensure dosage markings are accurately positioned. The in-mold labeling process eliminates the need for a secondary pad-printing or labeling operation (in-mold labeling cell, CBW Automation, 45-micron labels, Inland Label).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here